{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T17:28:27Z","timestamp":1749144507385,"version":"3.37.3"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2021,3,21]],"date-time":"2021-03-21T00:00:00Z","timestamp":1616284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,3,21]],"date-time":"2021-03-21T00:00:00Z","timestamp":1616284800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1007\/s00417-021-05142-y","type":"journal-article","created":{"date-parts":[[2021,3,21]],"date-time":"2021-03-21T15:02:26Z","timestamp":1616338946000},"page":"2679-2686","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Choroidal neovascularization secondary to pathological myopia\u2014macular Bruch membrane defects as prognostic factor to anti-VEGF treatment"],"prefix":"10.1007","volume":"259","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2261-5682","authenticated-orcid":false,"given":"Jo\u00e3o","family":"Coelho","sequence":"first","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8577-5128","authenticated-orcid":false,"given":"Andr\u00e9","family":"Ferreira","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4842-8623","authenticated-orcid":false,"given":"Ana Carolina","family":"Abreu","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5040-6170","authenticated-orcid":false,"given":"S\u00edlvia","family":"Monteiro","sequence":"additional","affiliation":[]},{"given":"Maria Jo\u00e3o","family":"Furtado","sequence":"additional","affiliation":[]},{"given":"Miguel","family":"Gomes","sequence":"additional","affiliation":[]},{"given":"Miguel","family":"Lume","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2021,3,21]]},"reference":[{"issue":"8","key":"5142_CR1","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1016\/j.ophtha.2006.04.022","volume":"113","author":"A Iwase","year":"2006","unstructured":"Iwase A, Araie M, Tomidokoro A, Yamamoto T, Shimizu H, Kitazawa Y, Tajimi Study G (2006) Prevalence and causes of low vision and blindness in a Japanese adult population: the Tajimi Study. Ophthalmology 113(8):1354\u20131362. https:\/\/doi.org\/10.1016\/j.ophtha.2006.04.022","journal-title":"Ophthalmology"},{"issue":"7","key":"5142_CR2","doi-asserted-by":"publisher","first-page":"1134 e1131","DOI":"10.1016\/j.ophtha.2006.01.035","volume":"113","author":"L Xu","year":"2006","unstructured":"Xu L, Wang Y, Li Y, Wang Y, Cui T, Li J, Jonas JB (2006) Causes of blindness and visual impairment in urban and rural areas in Beijing: the Beijing Eye Study. Ophthalmology 113(7):1134 e1131\u20131134 e1111. https:\/\/doi.org\/10.1016\/j.ophtha.2006.01.035","journal-title":"Ophthalmology"},{"issue":"1","key":"5142_CR3","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.ajo.2013.08.010","volume":"157","author":"TY Wong","year":"2014","unstructured":"Wong TY, Ferreira A, Hughes R, Carter G, Mitchell P (2014) Epidemiology and disease burden of pathologic myopia and myopic choroidal neovascularization: an evidence-based systematic review. Am J Ophthalmol 157(1):9\u201325 e12. https:\/\/doi.org\/10.1016\/j.ajo.2013.08.010","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"5142_CR4","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1001\/archopht.116.5.653","volume":"116","author":"CC Klaver","year":"1998","unstructured":"Klaver CC, Wolfs RC, Vingerling JR, Hofman A, de Jong PT (1998) Age-specific prevalence and causes of blindness and visual impairment in an older population: the Rotterdam Study. Arch Ophthalmol 116(5):653\u2013658. https:\/\/doi.org\/10.1001\/archopht.116.5.653","journal-title":"Arch Ophthalmol"},{"issue":"8","key":"5142_CR5","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1016\/s0161-6420(96)30515-0","volume":"103","author":"SY Cohen","year":"1996","unstructured":"Cohen SY, Laroche A, Leguen Y, Soubrane G, Coscas GJ (1996) Etiology of choroidal neovascularization in young patients. Ophthalmology 103(8):1241\u20131244. https:\/\/doi.org\/10.1016\/s0161-6420(96)30515-0","journal-title":"Ophthalmology"},{"issue":"6","key":"5142_CR6","doi-asserted-by":"publisher","first-page":"554","DOI":"10.22608\/APO.2017308","volume":"6","author":"DSC Ng","year":"2017","unstructured":"Ng DSC, Lai TYY, Cheung CMG, Ohno-Matsui K (2017) Anti-vascular endothelial growth factor therapy for myopic choroidal neovascularization. Asia Pac J Ophthalmol (Phila) 6(6):554\u2013560. https:\/\/doi.org\/10.22608\/APO.2017308","journal-title":"Asia Pac J Ophthalmol (Phila)"},{"issue":"2","key":"5142_CR7","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1097\/00006982-199212020-00009","volume":"12","author":"HE Grossniklaus","year":"1992","unstructured":"Grossniklaus HE, Green WR (1992) Pathologic findings in pathologic myopia. Retina 12(2):127\u2013133. https:\/\/doi.org\/10.1097\/00006982-199212020-00009","journal-title":"Retina"},{"issue":"12","key":"5142_CR8","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1016\/s0161-6420(84)34116-1","volume":"91","author":"MP Avila","year":"1984","unstructured":"Avila MP, Weiter JJ, Jalkh AE, Trempe CL, Pruett RC, Schepens CL (1984) Natural history of choroidal neovascularization in degenerative myopia. Ophthalmology 91(12):1573\u20131581. https:\/\/doi.org\/10.1016\/s0161-6420(84)34116-1","journal-title":"Ophthalmology"},{"issue":"8","key":"5142_CR9","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1016\/j.ophtha.2009.11.003","volume":"117","author":"K Hayashi","year":"2010","unstructured":"Hayashi K, Ohno-Matsui K, Shimada N, Moriyama M, Kojima A, Hayashi W, Yasuzumi K, Nagaoka N, Saka N, Yoshida T, Tokoro T, Mochizuki M (2010) Long-term pattern of progression of myopic maculopathy: a natural history study. Ophthalmology 117(8):1595\u20131611, 1611 e1591-1594. https:\/\/doi.org\/10.1016\/j.ophtha.2009.11.003","journal-title":"Ophthalmology"},{"issue":"1","key":"5142_CR10","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1007\/s10384-014-0363-z","volume":"59","author":"SY Cohen","year":"2015","unstructured":"Cohen SY, Nghiem-Buffet S, Grenet T, Dubois L, Ayrault S, Fajnkuchen F, Delahaye-Mazza C, Quentel G, Tadayoni R (2015) Long-term variable outcome of myopic choroidal neovascularization treated with ranibizumab. Jpn J Ophthalmol 59(1):36\u201342. https:\/\/doi.org\/10.1007\/s10384-014-0363-z","journal-title":"Jpn J Ophthalmol"},{"issue":"9","key":"5142_CR11","doi-asserted-by":"publisher","first-page":"1944","DOI":"10.1016\/j.ophtha.2013.06.010","volume":"120","author":"A Tufail","year":"2013","unstructured":"Tufail A, Narendran N, Patel PJ, Sivaprasad S, Amoaku W, Browning AC, Osoba O, Gale R, George S, Lotery AJ, Majid M, McKibbin M, Menon G, Andrews C, Brittain C, Osborne A, Yang Y (2013) Ranibizumab in myopic choroidal neovascularization: the 12-month results from the REPAIR study. Ophthalmology 120(9):1944\u20131945 e1941. https:\/\/doi.org\/10.1016\/j.ophtha.2013.06.010","journal-title":"Ophthalmology"},{"issue":"3","key":"5142_CR12","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.ophtha.2013.10.023","volume":"121","author":"S Wolf","year":"2014","unstructured":"Wolf S, Balciuniene VJ, Laganovska G, Menchini U, Ohno-Matsui K, Sharma T, Wong TY, Silva R, Pilz S, Gekkieva M, Group RS (2014) RADIANCE: a randomized controlled study of ranibizumab in patients with choroidal neovascularization secondary to pathologic myopia. Ophthalmology 121(3):682\u2013692 e682. https:\/\/doi.org\/10.1016\/j.ophtha.2013.10.023","journal-title":"Ophthalmology"},{"issue":"6","key":"5142_CR13","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1016\/j.ophtha.2015.01.025","volume":"122","author":"Y Ikuno","year":"2015","unstructured":"Ikuno Y, Ohno-Matsui K, Wong TY, Korobelnik JF, Vitti R, Li T, Stemper B, Asmus F, Zeitz O, Ishibashi T, Investigators M (2015) Intravitreal aflibercept injection in patients with myopic choroidal neovascularization: the MYRROR study. Ophthalmology 122(6):1220\u20131227. https:\/\/doi.org\/10.1016\/j.ophtha.2015.01.025","journal-title":"Ophthalmology"},{"issue":"7","key":"5142_CR14","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1016\/S0161-6420(03)00461-5","volume":"110","author":"T Yoshida","year":"2003","unstructured":"Yoshida T, Ohno-Matsui K, Yasuzumi K, Kojima A, Shimada N, Futagami S, Tokoro T, Mochizuki M (2003) Myopic choroidal neovascularization: a 10-year follow-up. Ophthalmology 110(7):1297\u20131305. https:\/\/doi.org\/10.1016\/S0161-6420(03)00461-5","journal-title":"Ophthalmology"},{"issue":"5","key":"5142_CR15","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1136\/bjo.87.5.570","volume":"87","author":"K Ohno-Matsui","year":"2003","unstructured":"Ohno-Matsui K, Yoshida T, Futagami S, Yasuzumi K, Shimada N, Kojima A, Tokoro T, Mochizuki M (2003) Patchy atrophy and lacquer cracks predispose to the development of choroidal neovascularisation in pathological myopia. Br J Ophthalmol 87(5):570\u2013573. https:\/\/doi.org\/10.1136\/bjo.87.5.570","journal-title":"Br J Ophthalmol"},{"issue":"6","key":"5142_CR16","doi-asserted-by":"publisher","first-page":"e470","DOI":"10.1111\/aos.12372","volume":"92","author":"JB Jonas","year":"2014","unstructured":"Jonas JB, Holbach L, Panda-Jonas S (2014) Bruch\u2019s membrane thickness in high myopia. Acta Ophthalmol 92(6):e470\u2013e474. https:\/\/doi.org\/10.1111\/aos.12372","journal-title":"Acta Ophthalmol"},{"issue":"5","key":"5142_CR17","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1111\/j.1600-0420.2007.01127.x","volume":"86","author":"N Lassota","year":"2008","unstructured":"Lassota N, Kiilgaard JF, la Cour M, Scherfig E, Prause JU (2008) Natural history of choroidal neovascularization after surgical induction in an animal model. Acta Ophthalmol 86(5):495\u2013503. https:\/\/doi.org\/10.1111\/j.1600-0420.2007.01127.x","journal-title":"Acta Ophthalmol"},{"issue":"3","key":"5142_CR18","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1001\/jamaophthalmol.2013.5799","volume":"132","author":"AC Bird","year":"2014","unstructured":"Bird AC, Phillips RL, Hageman GS (2014) Geographic atrophy: a histopathological assessment. JAMA Ophthalmol 132(3):338\u2013345. https:\/\/doi.org\/10.1001\/jamaophthalmol.2013.5799","journal-title":"JAMA Ophthalmol"},{"issue":"2","key":"5142_CR19","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1167\/iovs.12-11352","volume":"54","author":"JB Jonas","year":"2013","unstructured":"Jonas JB, Ohno-Matsui K, Spaide RF, Holbach L, Panda-Jonas S (2013) Macular Bruch\u2019s membrane defects and axial length: association with gamma zone and delta zone in peripapillary region. Investig Ophthalmol Vis Sci 54(2):1295\u20131302. https:\/\/doi.org\/10.1167\/iovs.12-11352","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"1","key":"5142_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00417-012-2022-8","volume":"251","author":"A Oishi","year":"2013","unstructured":"Oishi A, Yamashiro K, Tsujikawa A, Ooto S, Tamura H, Nakata I, Miyake M, Yoshimura N (2013) Long-term effect of intravitreal injection of anti-VEGF agent for visual acuity and chorioretinal atrophy progression in myopic choroidal neovascularization. Graefes Arch Clin Exp Ophthalmol 251(1):1\u20137. https:\/\/doi.org\/10.1007\/s00417-012-2022-8","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"4","key":"5142_CR21","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1159\/000357290","volume":"231","author":"CL Farinha","year":"2014","unstructured":"Farinha CL, Baltar AS, Nunes SG, Figueira JP, Pires IA, Cachulo ML, Silva RM (2014) Progression of myopic maculopathy after treatment of choroidal neovascularization. Ophthalmologica 231(4):211\u2013220. https:\/\/doi.org\/10.1159\/000357290","journal-title":"Ophthalmologica"},{"key":"5142_CR22","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.ajo.2015.11.014","volume":"162","author":"K Ohno-Matsui","year":"2016","unstructured":"Ohno-Matsui K, Jonas JB, Spaide RF (2016) Macular Bruch membrane holes in choroidal neovascularization-related myopic macular atrophy by swept-source optical coherence tomography. Am J Ophthalmol 162:133\u2013139 e131. https:\/\/doi.org\/10.1016\/j.ajo.2015.11.014","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"5142_CR23","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1023\/a:1025488429802","volume":"24","author":"F Bottoni","year":"2001","unstructured":"Bottoni F, Tilanus M (2001) The natural history of juxtafoveal and subfoveal choroidal neovascularization in high myopia. Int Ophthalmol 24(5):249\u2013255. https:\/\/doi.org\/10.1023\/a:1025488429802","journal-title":"Int Ophthalmol"},{"issue":"1","key":"5142_CR24","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s00417-004-0960-5","volume":"243","author":"K Hayashi","year":"2005","unstructured":"Hayashi K, Ohno-Matsui K, Yoshida T, Kobayashi K, Kojima A, Shimada N, Yasuzumi K, Futagami S, Tokoro T, Mochizuki M (2005) Characteristics of patients with a favorable natural course of myopic choroidal neovascularization. Graefes Arch Clin Exp Ophthalmol 243(1):13\u201319. https:\/\/doi.org\/10.1007\/s00417-004-0960-5","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"11","key":"5142_CR25","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1136\/bjophthalmol-2012-302973","volume":"97","author":"JM Ruiz-Moreno","year":"2013","unstructured":"Ruiz-Moreno JM, Arias L, Montero JA, Carneiro A, Silva R (2013) Intravitreal anti-VEGF therapy for choroidal neovascularisation secondary to pathological myopia: 4-year outcome. Br J Ophthalmol 97(11):1447\u20131450. https:\/\/doi.org\/10.1136\/bjophthalmol-2012-302973","journal-title":"Br J Ophthalmol"},{"issue":"3","key":"5142_CR26","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1007\/s00417-015-3076-1","volume":"254","author":"V Sarao","year":"2016","unstructured":"Sarao V, Veritti D, Macor S, Lanzetta P (2016) Intravitreal bevacizumab for choroidal neovascularization due to pathologic myopia: long-term outcomes. Graefes Arch Clin Exp Ophthalmol 254(3):445\u2013454. https:\/\/doi.org\/10.1007\/s00417-015-3076-1","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"5","key":"5142_CR27","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/j.ajo.2015.01.022","volume":"159","author":"K Ohno-Matsui","year":"2015","unstructured":"Ohno-Matsui K, Kawasaki R, Jonas JB, Cheung CM, Saw SM, Verhoeven VJ, Klaver CC, Moriyama M, Shinohara K, Kawasaki Y, Yamazaki M, Meuer S, Ishibashi T, Yasuda M, Yamashita H, Sugano A, Wang JJ, Mitchell P, Wong TY, Group ME-afPMS (2015) International photographic classification and grading system for myopic maculopathy. Am J Ophthalmol 159(5):877\u2013883 e877. https:\/\/doi.org\/10.1016\/j.ajo.2015.01.022","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"5142_CR28","doi-asserted-by":"publisher","first-page":"511","DOI":"10.5301\/ejo.5000839","volume":"26","author":"N Leveziel","year":"2016","unstructured":"Leveziel N, Gaucher D, Baillif S, Benouaich X, Chartier C, Grenet T, Gualino V, Krivosic V, Delyfer MN (2016) Understanding the determinants of myopic choroidal neovascularization and response to treatment. Eur J Ophthalmol 26(6):511\u2013516. https:\/\/doi.org\/10.5301\/ejo.5000839","journal-title":"Eur J Ophthalmol"},{"key":"5142_CR29","doi-asserted-by":"publisher","first-page":"3150923","DOI":"10.1155\/2018\/3150923","volume":"2018","author":"B Liu","year":"2018","unstructured":"Liu B, Zhang X, Mi L, Chen L, Wen F (2018) Long-term natural outcomes of simple hemorrhage associated with lacquer crack in high myopia: a risk factor for myopic CNV? J Ophthalmol 2018:3150923. https:\/\/doi.org\/10.1155\/2018\/3150923","journal-title":"J Ophthalmol"},{"key":"5142_CR30","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.2147\/OPTH.S124518","volume":"11","author":"CS Tan","year":"2017","unstructured":"Tan CS, Sadda SR (2017) Anti-vascular endothelial growth factor therapy for the treatment of myopic choroidal neovascularization. Clin Ophthalmol 11:1741\u20131746. https:\/\/doi.org\/10.2147\/OPTH.S124518","journal-title":"Clin Ophthalmol"},{"key":"5142_CR31","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.ajo.2016.03.019","volume":"166","author":"K Ohno-Matsui","year":"2016","unstructured":"Ohno-Matsui K, Jonas JB, Spaide RF (2016) Macular Bruch membrane holes in highly myopic patchy chorioretinal atrophy. Am J Ophthalmol 166:22\u201328. https:\/\/doi.org\/10.1016\/j.ajo.2016.03.019","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"5142_CR32","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.ophtha.2013.06.013","volume":"121","author":"QS You","year":"2014","unstructured":"You QS, Peng XY, Xu L, Chen CX, Wang YX, Jonas JB (2014) Myopic maculopathy imaged by optical coherence tomography: the beijing eye study. Ophthalmology 121(1):220\u2013224. https:\/\/doi.org\/10.1016\/j.ophtha.2013.06.013","journal-title":"Ophthalmology"},{"key":"5142_CR33","doi-asserted-by":"crossref","unstructured":"Spaide RF, Ohno-Matsui K, Yannuzzi LA (2014) Pathologic myopia. 113\u2013132","DOI":"10.1007\/978-1-4614-8338-0"},{"issue":"8","key":"5142_CR34","doi-asserted-by":"publisher","first-page":"e0136833","DOI":"10.1371\/journal.pone.0136833","volume":"10","author":"JB Jonas","year":"2015","unstructured":"Jonas JB, Wang YX, Zhang Q, Liu Y, Xu L, Wei WB (2015) Macular Bruch\u2019s membrane length and axial length. The Beijing Eye Study. PloS one 10(8):e0136833. https:\/\/doi.org\/10.1371\/journal.pone.0136833","journal-title":"PloS one"},{"key":"5142_CR35","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/B978-0-12-805313-3.00011-9","volume-title":"Chapter 11 - high myopia","author":"JM Ruiz-Moreno","year":"2017","unstructured":"Ruiz-Moreno JM, Flores-Moreno I, Ruiz-Medrano J (2017) Chapter 11 - high myopia. In: Chhablani J, Ruiz-Medrano J (eds). Academic Press, Choroidal Disorders, pp 171\u2013183. https:\/\/doi.org\/10.1016\/B978-0-12-805313-3.00011-9"},{"issue":"5","key":"5142_CR36","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1136\/bjo.2009.163535","volume":"94","author":"T Wakabayashi","year":"2010","unstructured":"Wakabayashi T, Ikuno Y (2010) Choroidal filling delay in choroidal neovascularisation due to pathological myopia. Br J Ophthalmol 94(5):611\u2013615. https:\/\/doi.org\/10.1136\/bjo.2009.163535","journal-title":"Br J Ophthalmol"},{"issue":"4","key":"5142_CR37","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1097\/00006982-200208000-00004","volume":"22","author":"K Kobayashi","year":"2002","unstructured":"Kobayashi K, Mandai M, Suzuma I, Kobayashi H, Okinami S (2002) Expression of estrogen receptor in the choroidal neovascular membranes in highly myopic eyes. Retina 22(4):418\u2013422. https:\/\/doi.org\/10.1097\/00006982-200208000-00004","journal-title":"Retina"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-021-05142-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00417-021-05142-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-021-05142-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,23]],"date-time":"2021-08-23T02:08:40Z","timestamp":1629684520000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00417-021-05142-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,21]]},"references-count":37,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["5142"],"URL":"https:\/\/doi.org\/10.1007\/s00417-021-05142-y","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"type":"print","value":"0721-832X"},{"type":"electronic","value":"1435-702X"}],"subject":[],"published":{"date-parts":[[2021,3,21]]},"assertion":[{"value":"1 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics approval approved.Consent to participate not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}